Document:

exv10w33

 

Exhibit 10.33

Consulting Agreement

THIS AGREEMENT (this “Agreement”) made and entered into this
9th Day of November by and between OCULUS INNOVATIVE
SCIENCES INC. (hereinafter “Oculus”), a California Corporation and
Robert C. Burlingame (hereinafter “Advisor”).

WHEREAS, Oculus desires that Advisor provide certain global planning
expertise and general business management services to Oculus (such services,
including all know-how, trade secrets, copyrights and patentable
inventions, being hereinafter referred to collectively as the
“Materials”);

WHEREAS, both Oculus and Advisor desire to set forth in writing the
terms and conditions of their dealings, including rights as to the
Materials;

NOW THEREFORE, in consideration of the premises hereof and the mutual
covenants and conditions hereinafter set forth and other good and
valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties hereto, intending to be legally
bound, hereby agree as follows:

Section 1. ADVISOR’S SERVICES

	1.1	 	On the terms and conditions set forth herein, Oculus hereby engages Advisor during
the term described below, and Advisor hereby accepts such engagement, to provide the
following services to Oculus:

	 	•	 	Global business review of the US and international
operations,
	 
	 	•	 	Creation of key performance
indicators to track Oculus’s performance on certain
ongoing and future company-wide projects, and
	 
	 	•	 	General business advice to US and international management

	 	 	Advisor agrees to use its best efforts, at a level consistent
with persons having a similar level of education, experience and
expertise in the industry, in the performance of the services
called for hereunder. This Agreement is nonexclusive.

Section 2. TERM OF AGREEMENT

	2.1	 	The term of this Agreement shall be for two (2) years
commencing upon the full
execution of this Agreement (the “Effective Date”) and may renewed by mutual
written agreement between Oculus and Advisor.

Section 3. INDEPENDENT CONTRACTOR

	3.1	 	Advisor agrees that he shall be an independent contractor acting for or on behalf of
Oculus. Advisor shall have no authority to contract for or bind Oculus in any manner.
Advisor shall have no status as employee or any right to any benefits that Oculus
grants its employees.

 

 

Section 4. COMPENSATION

	 	 	As compensation for Advisor’s services to the Company, subject to
the availability of an exemption from securities registration and
compliance with all applicable securities laws, the Advisor shall
be granted a warrant to purchase Three Hundred Thousand (300,000) shares of Common Stock of the Company at an exercise price per
share of $3.25 (the “Warrant”), pursuant to the Company’s standard
form of warrant agreement, with such changes as the Company’s
Board of Directors shall approve. The Warrant shall immediately
vest upon execution of this Agreement.
	 
	 	 	The Warrants must be exercised within ten (10) years after
the Effective Date;
provided, however, that if the Advisor is requested to
resign, the Warrants must be
exercised, in whole or in part (but only with respect to
such shares as are vested),
within thirty (30) days after such resignation or removal
or termination of this
Agreement.
	 
	 	 	The Warrants and the underlying shares of the Company’s
Common Stock issuable
upon conversion thereof (the “Conversion Shares”) shall be
subject to certain
restrictions and legends as shall be specified in any
documents authorizing the Warrant and the Conversion Shares. The
Warrants and the Conversion Shares shall not be issued unless the
issuance and delivery of such Warrants and Conversion Shares shall
comply with all relevant provisions of law, including, without
limitation, the Securities Act of 1933, as amended (the “33 Act”),
the Securities Exchange Act of 1934, as amended, the rules and
regulations promulgated thereunder, and the requirements of any
stock exchange or quotation system upon which the Conversion.
Shares may then be listed or quoted, and shall be further subject
to the approval of counsel for the Company with respect to such
compliance. Inability of the Company to obtain authority from any
regulatory body having jurisdiction, which authority is deemed by
the Company’s counsel to be necessary to the lawful issuance of
any of the Conversion Shares, shall relieve the Company of any
liability in respect of the non issuance of the Warrants and any
Conversion Shares as to which such requisite authority shall not
have been obtained.
	 
	 	 	     The Advisor represents and warrants that it is acquiring or
will acquire the Warrants and, as applicable, the Conversion
Shares, solely for its account for investment and not with a
view-to or for sale or distribution of said Warrants or
Conversion Shares or any part thereof. The Advisor also
represents that the entire legal and beneficial interest of the
Warrants, and the Conversion Shares, is being acquired for, and
will be held for,
his/her account only. Advisor represents that (i) he/she has
a preexisting personal or
business relationship with the Company or one or more of its
officers, directors or
controlling persons, (ii) that by reason of his/her business
or financial experience, or
the business or financial experience of his/her financial
experience, or the business or financial experience of his/her
professional advisers, could be reasonably assumed to have the
capacity to protect his/her own interests in connection wit this
transaction,
and/or (iii) that he/she is an accredited investor, as that
term is defined in Section
501 (a) of Regulation D promulgated under the ’33 Act.

Page 2 of 5

 

 

Section 5. OBLIGATION FOR EXPENSE

	5.1	 	Oculus will reimburse Advisor for reasonable and appropriate out-of-pocket travel
expenses according to a budget submitted by Advisor to, and approved by, Oculus.
Advisor shall be responsible for submitting a monthly expense report
to Oculus for reasonable reimbursable expenses incurred by Advisor. Oculus
shall have no duty or
obligation to reimburse expenses for which a monthly expense
report has not been
submitted. From time to time, in anticipation of certain
expenses such as airfare,
extended travel and living expenses, Oculus may advance certain
monies to Advisor
pursuant to an expense budget mutually agreed upon by Oculus and
Advisor. Any
expense exceeding One Thousand ($1,000) Dollars will require
pre-approval by
Oculus.

Section 6.
OWNERSHIP OF MATERIALS

	6.1	 	Advisor agrees that all Materials, reports and other data or materials generated or
developed by Advisor under this Agreement or furnished by Oculus to Advisor shall
be and remain the property of Oculus. Advisor specifically agrees that all
copyrightable Material generated or developed under this Agreement shall be
considered works made for hire and that such material shall,
upon creation, be owned
exclusively by Oculus. To the extend that any such Material,
under applicable law,
may not be considered works made for hire, Advisor hereby
assigns to Oculus the
ownership of copyright in such Materials, without the necessity
of any further
consideration, and Oculus shall be entitled to obtain and hold
in its own name all
copyrights in respect of such Materials.

	6.2	 	If and to the extend Advisor may, under applicable law, be entitled to claim any
ownership interest in the Materials, reports and other data
or materials generated or developed by Advisor under this
Agreement, Advisor hereby transfers, grants, conveys, assigns and
relinquishes exclusively to Oculus all of Advisor’s right, title
and interest in and to such Materials, under patent, copyright,
trade, secret and trademark
law, in perpetuity or for the longest period otherwise permitted by law.
	 
	6.3	 	Advisor shall perform any acts that may be deemed necessary or
desirable by Oculus
to evidence more fully transfer of ownership of all Materials designated under this
Section 6 to Oculus to the fullest extent possible, including but not limited to the
making of further written assignments in a form determined by Oculus.
	 
	6.4	 	To the extent that any preexisting rights are embodied or reflected in the Materials,
Advisor hereby grants to Oculus the irrevocable, perpetual, non-exclusive, worldwide,
royalty-free right and license to (1) use, execute, reproduce, display, perform,
distribute copies of, and prepare derivative works based upon such preexisting
rights and any derivate works thereof and (2) authorize others to do any or all of the
foregoing.

Page 3 of 5

 

 

	6.5	 	Advisor hereby represents and warrants that it has full right and authority to
perform,
its obligations and grant the rights and licenses herein
granted and that it has neither assigned nor otherwise entered
into an agreement by which it purports to assign or transfer
any right, title, or interest to any technology or intellectual
property right that would conflict with its obligations under
this Agreement. Advisor covenants and agrees that it shall not
enter into any such agreements.

Section 7. PROTECTION OF PROPRIETARY MATERIALS

	7.1	 	From the date of execution hereof and for as long as the
information or data remain
Trade Secrets, Advisor shall not use, disclose, or permit any
person to obtain any
Trade Secrets of Oculus, including any materials developed or
generated hereunder (whether or not the Trade Secrets are in
written or tangible form), except as specifically authorized
by Oculus.
	 
	7.2	 	As used herein, “Trade Secret” shall mean a whole or any portion or phase of any
scientific or technical information, design, process, procedure, formula, or
improvement that is valuable and not generally known to competitors of Oculus.
	 
	7.3	 	Irreparable harm should be presumed if Advisor breaches any covenant in this
Agreement for any reason, This Agreement is intended to protect
Oculus’s proprietary
rights pertaining to the Materials, and any misuse of such
rights would cause
substantial balm to Oculus’s business. Therefore, Advisor
agrees that a court of
competent jurisdiction should immediately enjoin any breach of
this Agreement, upon
a request by Oculus.

Section 8. RETURN OF MATERIALS

	8.1	 	Upon the request of Oculus, but in any event upon termination of this Agreement,
Advisor shall surrender to Oculus all memoranda, notes, records, drawings, manuals,
computer services and other documents or materials (and all copies of same)
pertaining to the Materials, reports and other data or materials
generated or developed by Advisor or furnished by Oculus to the
Advisor, including all materials embodying any Trade Secrets.
This Section is intended to apply to all materials made or
compiled by Advisor, as well as to all materials furnished to
Advisor by Oculus or by anyone else that pertain to the
Materials.

Section 9.
SCOPE OF AGREEMENT

	9.1	 	This Agreement is intended by the parties hereto to be the final
expression of their
agreement and it constitutes the full and entire understanding
between the parties with
respect to the subject hereof, notwithstanding any
representations, statements, or
agreements to the contrary heretofore made. This Agreement may
be amended only in
writing signed by the parties to this Agreement.

Page 4 of 5

 

 

	9.2	 	For purpose of enforcing this Agreement, all sections of this Agreement, except
Section 4.1 hereof, shall be construed as covenants independent of one another
and as
obligations distinct from all other contracts and agreements between the
parties hereto.

Section 10. TERMINATION

	10.1	 	This Agreement may be terminated by either party upon 30-days
prior written notice to
the other party. Te respective obligations and covenants of the
parties and this
Agreement, which by their nature extend beyond the expiration or
termination of this
agreement, including, without limitation, its confidentiality and
warranty provisions,
shall survive the termination or expiration of this Agreement.

Section 11. GOVERNING LAW

	11.1	 	This Agreement is made under and in all respects shall. be
interpreted, construed and
governed by and in accordance with the Laws of the State of
California. Sole and
exclusive jurisdiction in any case or controversy arising
under this. Agreement or by
reason of this Agreement shall be with the Sonoma County
Superior Court or the United States District Court for the
Northern District of California, and for this
purpose each party hereby expressly and irrevocably consents to the exclusive
jurisdiction of such courts.

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to
be duly executed on the day and year first above written.

	 	 	 	 	 	 	 
	 	 	OCULUS INNOVATIVE SCIENCES INC.	 	 
	 
	 	 	 	 	 	 
	     /s/ Robert C. Burlingame

	 	By:
	 	     /s/ H. Alimi	 	 
	 

	 	 	 	 	 	 
	Robert C. Burlingame

	 	 	 	Hojabr Alimi, Chief Executive Officer	 	 
	 
	 	 	 	 	 	 
	Date: November 8, 2006	 	Date: November 8, 2006exv10w34

 

Exhibit 10.34

DIRECTOR AGREEMENT

     THIS DIRECTOR AGREEMENT (“Agreement”) is dated for reference
purposes only as of this 8th day of November 2006, by and between ROBERT
C. BURLINGAME (the “Director”) and OCULUS INNOVATIVE SCIENCES, INC.,
a California corporation (the “Company”), and, subject to the prior
amendment of Section 2.10 of the Bylaws, shall become effective as of the
date the requisite affirmative vote of the holders of Series A Preferred
Stock of the Company in favor of the election of Director shall be
obtained (the “Effective Date”) .

     WHEREAS, the Company is engaged in the business of
developing and manufacturing products for the anti
-infection and wound management markets ;

     WHEREAS, as of the Effective Date, the Director will be a duly
elected director of the Company;

     WHEREAS, the Company and the Director desire that the confidentiality
obligations of the Director and the indemnification obligations of the
Company be memorialized by this Agreement; and

     WHEREAS, the Company desires that the Director be compensated
for his services to the Company by the granting of options to purchase
the stock of the Company on the terms provided herein.

     NOW, THEREFORE, in consideration of the foregoing premises and the mutual
covenants herein contained, the parties hereto agree as follows:

     1. Director
Availability. The Director shall make himself
reasonably available to attend the noticed meetings of the Board of
Directors of the Company at the Company’s Petaluma offices, and if not
practicable, by telephone conference call. The Director shall make himself
reasonably available to the officers of the Company for purpose of general
consultation in connection with the business of the Company.

     2. Competing Activities. While a director of the Company, the
Director shall not engage in any other employment, occupation, consulting or
other business activity that is directly competitive with the business of
the Company.

     3. Covenant Not to Solicit. For the period beginning on the
date hereof and ending on the date one (1) year after the completion or
termination of the Director’s engagement with the Company, the Director
shall not either directly or indirectly solicit, induce, recruit or
encourage any of the Company’s employees to leave their employment, or

Director Agreement

Oculus Innovative Sciences, Inc.

1

 

take away such employees, or attempt to solicit, induce, recruit, encourage or take
away employees of the Company, either for the Director or for any other person or
entity.

     4. Confidential Information. The Director acknowledges that during the
course of his engagement with the Company that he will produce and have
access to information relating to personnel, sales, forecasts, customers and
financial, operational and scientific matters of the Company, whether
developed by the Director or by others (collectively, “Confidential
Information”). The Director understands that any and all Confidential
Information is received or developed by him and is disclosed to him in
confidence, and is to be used only for the purposes for which it is provided.
During the term of his engagement with the Company or thereafter, the
Director shall not directly or indirectly, except as required by the normal
business of the Company or expressly consented to in writing by the Board of
Directors of the Company: (i) disclose, publish or make available any
Confidential Information, other than to an employee, officer or director of
the Company who, in the reasonable exercise of the Director’s judgment, needs
to know such Confidential. Information in order to perform his duties to the
Company; (ii) sell, transfer or otherwise use or exploit or permit the sale,
transfer, use or exploitation of the Confidential Information for any
purposes other than those for which they were provided; or (iii) remove from
the Company’s premises or retain upon termination of his engagement any
Confidential Information, any copies thereof or any tangible or retrievable
materials containing or constituting Confidential Information. The Director
further agrees that all files, letters, memos, reports, sketches, drawings,
customer lists, telephone lists or other written material containing
Confidential Information which shall come into his possession shall be the
exclusive property of the Company to be used only in the performance of
Company duties. All such written materials shall be delivered to the Company
upon termination of the Director’s engagement with the Company.

     The restrictions on the use or disclosure of Confidential
Information shall not apply to any information that the Director can
document is or was: (i) independently developed by the Director prior to
the time of disclosure; (ii) in the public domain without breach of this
Agreement and through no fault of the Director; (iii) at the time of
disclosure to the Director properly known to such party free of restriction
or lawfully received free of restriction from another source having the
right to so furnish such information; or (iv) which the Company agrees in
writing is free of such restrictions.

     5. Equitable Remedies. The Director agrees that it would be
impossible or inadequate to measure and calculate the Company’s damages from
any breach or threatened breach of the covenants set forth in sections 2, 3,
and 4 of this Agreement. Accordingly, the Director agrees that in the event
of any alleged breach or threatened breach of those sections, the Company
will have available, in addition to any other right or remedy available, the
right to obtain an injunction from a court of competent jurisdiction
restraining such alleged breach or threatened breach.

Director
Agreement

Oculus Innovative Sciences, Inc.

2

 

     6. Company Stock Options. As partial compensation for Director’s
services to the Company, the Director shall be granted an option to purchase
300,000 fully vested shares of Common Stock of the Company at an exercise price
of Three dollars and Twenty Five cents ($3.25) per share (the “Stock Options”).
The Stock Options must be exercised within ten (10) years after the date on which
the last vesting of the Stock Options occur; provided, however, that if the
Director is requested to resign for cause (as defined below) or is removed for
cause (as defined below), the Stock Options must be exercised, in whole or in
part, within thirty (30) days of such resignation or removal.

     The Stock Options and the underlying shares shall be subject to
certain restrictions and legends as shall be specified in any documents
authorizing such Stock Options and shares. The Stock Options and the
underlying shares shall not be issued unless the issuance and delivery of
such Stock Options and shares shall comply with all relevant provisions of
law, including, without limitation, the Securities Act of 1933, as amended,
the Securities Exchange Act of 1934, as amended, the rules ad regulations
promulgated thereunder, and the requirements of any stock exchange or
quotation system upon which the underlying shares may then be
listed or quoted, and shall be further subject to the approval of counsel
for the Company with respect to such compliance. Inability
of the Company to obtain authority from any regulatory body having
jurisdiction, which authority is deemed by the Company’s counsel to be
necessary to the lawful issuance of any underlying shares hereunder, shall
relieve the Company of any liability in respect of the non-issuance of
such Stock Options and shares as to which such requisite authority shall
not have been obtained.

     7. Expenses. The Director shall be entitled to reimbursement of his
reasonable expenses incurred on behalf of the Company and reimbursement to the
Director shall be due and made against an itemized list of such expenses. Any
expenses in excess of $100 shall require the prior approval of the Company.

     8. Indemnification. The Company will indemnify and defend the
Director against any liability incurred in the performance of his services to
the Company to the fullest extent authorized in. Company’s Articles of
Incorporation, bylaws, and applicable law. The Company has purchased
Director’s and Officer’s liability insurance, and Director shall be entitled
to the protection of any insurance policies the Company maintains for the benefit of its directors and officers against all costs, charges and expenses
in connection with any action, suit or proceeding to which he may be made a
party by reason of his affiliation with the Company, its subsidiaries, or
affiliates.

     9. Assignment by Director. This Agreement is personal, and
the Director’s rights and obligations under this Agreement are not and
shall not be transferable by assignment or otherwise. Any attempted
assignment in violation of this section 9 shall be voidable at the
Company’s option and shall entitle the Company to terminate the
Agreement.

Director
Agreement

Oculus Innovative Sciences, Inc.

3

 

     10. Assignment by the Comp. Nothing in this Agreement
shall prevent the consolidation of the Company with, or its merger
into, any other corporation or the assignment by the Company of this Agreement
and the performance of its obligations hereunder to any affiliated company.
If the Company shall merge into, sell, as sign or transfer
its operations to any successor, the Company shall have the right to assign all of
its right, title and interest in this Agreement to such successor; provided,
however, that such successor assumes and agrees to perform, from and after the
date of such assignment, all of the terms, conditions and provisions imposed
by this Agreement upon the Company. In the event of such an assignment by the
Company and of such assumption and agreement by a successor, all further rights,
as well as all further obligations, of the Company under this Agreement shall
cease and terminate, and thereafter, the term “the Company” wherever used herein
shall be deemed to refer to such. successor or assignee. This Agreement shall
inure to the benefit of, and be enforceable by, any corporate
successor to or assignee of the Company.

     11. Notice. Any notice to be given to the Company under
the terms of this Agreement shall be addressed to the Company
at the address of its principal place of business, and any notice to be
given to the Director shall be addressed to him at his home address last
shown on the records of the Company, or at such other address as either
party may hereafter designate in writing to the other. Any such notice shall
be deemed to have been duly given when enclosed in a properly sealed and
addressed envelope, registered or certified, and deposited (postage and
registry or certification. fee prepaid) in a post office or branch post
office regularly maintained by the United States government.

     12. Construction. The provisions of this Agreement are
divisible and, so far as they are covenants not to compete, shall be operative to the extent, both as to time and area covered, that they may be made
so applicable; if any provisions, or any part hereof, are declared invalid
or unenforceable, the validity and enforceability of the remainder of such
provisions, or parts hereof, and the applicability hereof shall not be
affected thereby.

     13. Waiver. Waiver of any term or condition contained in this
Agreement-by any party to this Agreement shall not be construed as a waiver
of a subsequent breach or failure of the same term or condition or a waiver
of any other term or condition contained in this Agreement.

     14. Applicable Law. The provisions of this Agreement shall be interpreted
under, and performance of the parties hereto shall be governed by, the laws of the
State of
California.

     15. Amendments. The provisions of this Agreement may be waived, amended,
modified, or repealed, in whole or in part, only on the written consent of all parties
to this
Agreement.

Director
Agreement

Oculus Innovative Sciences, Inc.

4

 

     16. Survival. The respective obligations and covenants of the parties
under this Agreement which shall by their nature extend beyond the expiration or
termination of this Agreement, including, without limitation, the confidentiality
and non -solicitation obligations of the Director and the indemnification
obligations of the Company, shall survive the termination or expiration of
this Agreement.

     17. Headings. The headings throughout this Agreement are
for the convenience and reference purposes only and shall not be deemed to
expand, modify, amplify, or aid in the interpretation, construction,
or meaning of any provision of this Agreement.

     18. Entire Agreement. The terms of this Agreement are
intended by the parties as a final expression of their agreement with respect
to such terms as are included in this Agreement, and such terms may not be
contradicted by evidence of any prior or contemporaneous agreement. The
parties further intend that this Agreement constitutes the complete and
exclusive statement of its terms and that no extrinsic evidence whatsoever
may be introduced in any judicial proceedings, if any, involving this
Agreement.

     IN WITNESS WHEREOF, the parties hereto have executed or caused
this Agreement to be executed as of the Effective Date.

	 	 	 	 	 	 	 	 	 	 
	 	 	The Director:	 	 	 	The Company:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Oculus Innovative Sciences, Inc.
	 	 	      /s/ Robert C. Burlingame	 	 	 	a California Corporation
	 

	 	 	 	 	 	 	 	 
	 

	 	Robert C. Burlingame	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	By:
	 	/s/ H. Alimi
	 

	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Its:
	 	President

Director
Agreement

Oculus Innovative Sciences, Inc.

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00114-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00114-of-00352.parquet"}]]